Goldschmidt, H., Bärtsch, M., Schlenzka, J., Becker, N., Habermehl, C., Hielscher, T., . . . Weisel, K. (2020). Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: The randomized GMMG phase III trial ReLApsE. Leukemia, 35(4), . https://doi.org/10.1038/s41375-020-0948-0
Chicago-Zitierstil (17. Ausg.)Goldschmidt, Hartmut, et al. "Salvage Autologous Transplant and Lenalidomide Maintenance Vs. Lenalidomide/dexamethasone for Relapsed Multiple Myeloma: The Randomized GMMG Phase III Trial ReLApsE." Leukemia 35, no. 4 (2020). https://doi.org/10.1038/s41375-020-0948-0.
MLA-Zitierstil (9. Ausg.)Goldschmidt, Hartmut, et al. "Salvage Autologous Transplant and Lenalidomide Maintenance Vs. Lenalidomide/dexamethasone for Relapsed Multiple Myeloma: The Randomized GMMG Phase III Trial ReLApsE." Leukemia, vol. 35, no. 4, 2020, https://doi.org/10.1038/s41375-020-0948-0.